Skip to Content

Raltitrexed

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01BA03

CAS registry number (Chemical Abstracts Service)

0112887-68-0

Chemical Formula

C21-H22-N4-O6-S

Molecular Weight

458

Therapeutic Categories

Antimetabolite

Cytostatic agent

Chemical Name

N-[5-[[(3,4-dihydro-2-metyl-4-oxo-6-quinazolinyl)metyl]metylamino]-2-tenoyl]-L-glutamic acid (WHO)

Foreign Names

  • Raltitrexedum (Latin)
  • Raltitrexed (German)
  • Raltitrexed (French)
  • Raltitrexed (Spanish)

Generic Names

  • Raltitrexed (OS: USAN, BAN, JAN)
  • D 1694 (IS: Zeneca)
  • ICI-D 1694 (IS: Zeneca)
  • Paltitrexid (IS)
  • ZD 1694 (IS: Zeneca)
  • ZN-D 1694 (IS: Zeneca)

Brand Names

  • Tomudex
    AstraZeneca, Brazil; AstraZeneca, Egypt; AstraZeneca, Spain; AstraZeneca, Lebanon; AstraZeneca, Lithuania; Hospira, Austria; Hospira, Australia; Hospira, Belgium; Hospira, Switzerland; Hospira, Czech Republic; Hospira, United Kingdom; Hospira, Hungary; Hospira, Iceland; Hospira, Norway; Hospira, Portugal; Hospira Italia, Italy; Orna, Turkey; Hospira, Canada

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

(web2)